Skip to main content
. 2022 Nov 14;13:1039843. doi: 10.3389/fimmu.2022.1039843

Figure 2.

Figure 2

Schematic representation of Anti-platelet drugs in use and under development. ASA, acetylsalicylic acid; CVD, cardiovascular disease; PVD, pulmonary vascular disease; CAD, coronary artery disease; MI, myocardial infarction; ACS, acute coronary syndrome; IV, intra veinous; PCI percutaneous coronary intervention.